{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T22:07:53Z","timestamp":1788732473426,"version":"build-2803163510"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.imlet.2019.03.002","type":"journal-article","created":{"date-parts":[[2019,3,5]],"date-time":"2019-03-05T16:34:38Z","timestamp":1551803678000},"page":"8-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Antinuclear antibodies in patients with cervical lesions and invasive cervical cancer"],"prefix":"10.1016","volume":"208","author":[{"given":"Thelma L.","family":"Skare","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline","family":"Neppel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana C.C.","family":"Machoski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos A.","family":"Maestri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iara","family":"Messias-Reason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato","family":"Nisihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imlet.2019.03.002_bib0005","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1034\/j.1600-065X.2002.18811.x","article-title":"Multiple pathways to tumor immunity and concomitant autoimmunity","volume":"188","author":"Turk","year":"2002","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.imlet.2019.03.002_bib0010","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.critrevonc.2018.05.002","article-title":"Antinuclear antibodies and cancer: a literature review","volume":"127","author":"Vlagea","year":"2018","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"15","key":"10.1016\/j.imlet.2019.03.002_bib0015","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1186\/s12885-015-1385-8","article-title":"Autoantibodies in breast cancer sera are not epiphenomena and may participate in carcinogenesis","volume":"201","author":"Madrid","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.imlet.2019.03.002_bib0020","doi-asserted-by":"crossref","first-page":"213","DOI":"10.4103\/0973-1482.183559","article-title":"Clinical significance of elevated antinuclear antibodies in patients with diffuse large B\u2011cell lymphoma: a single center study","volume":"14","author":"Lang","year":"2018","journal-title":"J. Cancer Res. Ther."},{"key":"10.1016\/j.imlet.2019.03.002_bib0025","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/cei.13136","article-title":"Anti-nuclear antibodies in patients with breast cancer","volume":"193","author":"Nisihara","year":"2018","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.imlet.2019.03.002_bib0030","first-page":"1393","article-title":"Antinuclear antibodies as potential markers of lung cancer","volume":"5","author":"Fern\u00e1ndez-Madrid","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.imlet.2019.03.002_bib0035","series-title":"Colposcopy and Treatment of Cervical Intraepithelial Neoplasia","first-page":"1","author":"Sellors","year":"2003"},{"key":"10.1016\/j.imlet.2019.03.002_bib0040","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1056\/NEJM199802123380703","article-title":"Natural history of cervicovaginal papillomavirus infection in young women","volume":"338","author":"Ho","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.imlet.2019.03.002_bib0045","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1470-2045(08)70103-7","article-title":"Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study","volume":"9","author":"McCredie","year":"2008","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.imlet.2019.03.002_bib0050","first-page":"53","article-title":"Antigens of carcinoma of the cervix uteri: a study by means of immunofluorescence","volume":"16","author":"Nelson","year":"1974","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.imlet.2019.03.002_bib0055","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3109\/03009742.2011.593546","article-title":"Antinuclear antibody status and risk of death in children and adolescents","volume":"40","author":"Chou","year":"2011","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.imlet.2019.03.002_bib0060","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/art.10561","article-title":"Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing","volume":"47","author":"Solomon","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2019.03.002_bib0065","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.autrev.2010.12.002","article-title":"Autoantibodies to tumor-associated antigens as biomarkers in cancer immunodiagnosis","volume":"10","author":"Liu","year":"2011","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.imlet.2019.03.002_bib0070","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1006\/clim.2001.5070","article-title":"Tumor immunity and autoimmunity: a case of Dr. Jekyll and Mr. Hyde","volume":"100","author":"Reeves","year":"2001","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.imlet.2019.03.002_bib0075","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1365-2249.2001.01585.x","article-title":"De\u2011novo humoral immune responses to cancer\u2011associated autoantigens during transition from chronic liver disease to hepatocellular carcinoma","volume":"125","author":"Zhang","year":"2001","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.imlet.2019.03.002_bib0080","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jbspin.2015.07.002","article-title":"Anti-pseudo-PCNA type 1 (anti-SG2NA) pattern: track down Cancer, not SLE","volume":"83","author":"Guffroy","year":"2016","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.imlet.2019.03.002_bib0085","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1158\/0008-5472.CAN-14-2278","article-title":"Optimizing a lupus autoantibody for targeted cancer therapy","volume":"75","author":"Noble","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.imlet.2019.03.002_bib0090","doi-asserted-by":"crossref","first-page":"59965","DOI":"10.18632\/oncotarget.11015","article-title":"A lupus anti-DNA autoantibody mediates autocatalytic, targeted delivery of nanoparticles to tumors","volume":"7","author":"Chen","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.imlet.2019.03.002_bib0095","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0003-4975(99)01198-4","article-title":"Antineural and antinuclear autoantibodies are of prognostic relevance in non\u2011small cell lung cancer","volume":"69","author":"Blaes","year":"2000","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.imlet.2019.03.002_bib0100","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1186\/s12885-015-1385-8","article-title":"Autoantibodies in breast cancer sera are not epiphenomena and may participate in carcinogenesis","volume":"15","author":"Madrid","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.imlet.2019.03.002_bib0105","doi-asserted-by":"crossref","first-page":"292","DOI":"10.12932\/AP0272.31.4.2013","article-title":"Sensitivity and specificity of ANA and anti-dsDNA in the diagnosis of systemic lupus erythematosus: a comparison using control sera obtained from healthy individuals and patients with multiple medical problems","volume":"31","author":"Wichainun","year":"2013","journal-title":"Asian Pac. J. Allergy Immunol."},{"key":"10.1016\/j.imlet.2019.03.002_bib0110","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.autrev.2014.03.001","article-title":"Increased risk of high grade cervical squamous intraepithelial lesions in systemic lupus erythematosus: a meta-analysis of the literature","volume":"13","author":"Zard","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.imlet.2019.03.002_bib0115","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00296-012-2426-0","article-title":"Prevalence of cervical human papillomavirus infection in women with systemic lupus erythematosus","volume":"33","author":"Lyrio","year":"2013","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.imlet.2019.03.002_bib0120","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1177\/0961203310372952","article-title":"Are women with lupus at higher risk of HPV infection?","volume":"19","author":"Klumb","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.imlet.2019.03.002_bib0125","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/BOR.0000000000000398","article-title":"Human papilloma virus and lupus: the virus, the vaccine and the disease","volume":"29","author":"Segal","year":"2017","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.imlet.2019.03.002_bib0130","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3389\/fimmu.2015.00116","article-title":"DFS70\/LEDGFp75: an enigmatic autoantigen at the interface between autoimmunity, AIDS, and cancer","volume":"6","author":"Basu","year":"2015","journal-title":"Front. Immunol."}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247819300513?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247819300513?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,29]],"date-time":"2020-11-29T06:43:26Z","timestamp":1606632206000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247819300513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":26,"alternative-id":["S0165247819300513"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2019.03.002","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antinuclear antibodies in patients with cervical lesions and invasive cervical cancer","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2019.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}